[Longevity Dispatch] Peptides, Statins, Screens: The Week the FDA Rattled Biohacking + Longevity Recipe
News from the longevity, biohacking, health, and supplement fronts.
By Valérie Orsoni — Biohacker & Longevity Expert Valérie Orsoni is a biohacker, author of 56 books, and founder of valbiohacker.com. She has been tracking her biology through N=1 self-experimentation protocols since 1998. She is recently completed her Stanford Genetics Longevity Research certification program and is currently enrolled in the Stanford Medicine nutrition science program. She was named in the Top 50 Longevity Leaders by Life Spanning magazine and is currently the #1 on the Longevity Cup Leaderboard (chronological age -23 years).
🧬 The Ultimate Guide to Biohacking & Longevity is a reader-supported publication. 💌 To receive new posts and support my work, consider becoming a free or paid subscriber. 🚀
July 26th, 2026 — ValBiohacker.com
🧬 Peptides: The FDA Decision That’s Freaking Everyone Out
“Turn off the TV” isn’t the only warning going around this week — “hide your peptides” is the one actually trending in biohacking circles right now.
On July 23-24, 2026, the FDA’s PCAC (Pharmacy Compounding Advisory Committee) met at White Oak to decide whether 7 of the community’s most-used peptides — BPC-157, KPV, TB-500, MOTS-c (7/23), then Emideltide, Semax, Epitalon (7/24) — get added to the 503A Bulks List, the roster of substances legally allowed in compounded prescriptions.
→ FDA briefing documents released ahead of the meeting recommend adding none of the 7 peptides → Cited reasons: insufficient characterization, thin human efficacy data, lack of safety data → Backstory: in April 2026, the FDA had already pulled these same peptides off the restricted-substances list, without moving them into Category 1 (permitted). They’ve been sitting in regulatory limbo ever since.
The real shock isn’t the decision itself, it’s the gap between what the community expected (roughly 14 of 19 restricted peptides returning to Category 1) and what FDA staff are actually recommending (zero).
⚠️ Caveat: this is an advisory recommendation, not a final ruling. Even a favorable committee vote would kick off a rulemaking process that typically takes 6 to 18 months before anything changes on the ground. Nothing shifts legally overnight — but the signal it sends to the compounding industry is immediate.
My N=1: Personally, I’m not panicking. I’m sticking with my peptide protocols. If peptides stop being available in the US, I have very reliable sources in China (yes, let’s not kid ourselves — even the best US and European labs source their raw materials from China).
Final decision: 6 peptides got a YES, and 1 got a NO (Emideltide). More on this in the coming months.
🧬 The Ultimate Guide to Biohacking & Longevity is a reader-supported publication. 💌 To receive new posts and support my work, consider becoming a free or paid subscriber. 🚀
“Turn off that TV, it’ll rot your brain” has been a household refrain for decades. A study just published in Alzheimer’s & Dementia gives it real scientific backing.
Researchers followed roughly 1,700 adults (average age 53) enrolled in the ARIC study between 1987 and 1989. They self-reported TV-watching frequency, then underwent brain MRI more than two decades later.
→ Heavy TV watchers (”very often”) showed smaller volumes in brain regions tied to early Alzheimer’s signs → Smaller frontal and occipital lobes (executive function and visual processing) → Greater white matter hyperintensity volume — a marker of small blood vessel disease linked to stroke risk and cognitive decline → Differences held even after controlling for physical activity, diabetes, BMI, smoking, and alcohol use
“For years we’ve focused on how much people sit. Our findings suggest we should also pay attention to what they’re doing while they’re sitting.” — David Raichlen, USC Dornsife
Here’s the twist: other sedentary activities showed no such association. So this isn’t just about sitting — it’s about something specific to TV watching, possibly the lack of active cognitive engagement, or its effect on circadian rhythm and sleep.
⚠️ Caveat: TV consumption was self-reported (less reliable than objective screen-time tracking), and there was no baseline MRI at study start — so this shows an association measured twenty years later, not a tracked change over time.
My N=1: I don’t watch TV, ever! Except in 3 occasions: World Soccer Cup (every 4 years), Super Bowl (once a year) and F1 (which I watch on my rowing machine or on my Peloton)
The new 2026 cholesterol guidelines don’t create more statin patients overall — they shift the typical profile toward younger, lower-risk adults. And that’s exactly the problem.
→ Per NHANES (2017-2023), 87.5 million U.S. adults (ages 30-79) are now statin-eligible → Of those, 21.5 million are newly eligible, with a notably lower 10-year cardiovascular risk than previously eligible patients (3.1% vs. 6.1%) → The key shift: adoption of the PREVENT risk equations, which produce lower risk estimates than the older model but also lower the treatment threshold (3-5% risk = “consider,” 5-10% = “recommended”) → Three JAMA studies agree: the overall eligible population stays roughly the same size, but its profile skews lower-risk, while higher-risk patients remain well short of their LDL targets
“This is a huge public health burden for a medical condition that should be highly treatable.” — JAMA editorial, Greenland & Lasser
⚠️ My take: the science on display here, recalibrated, on-paper-more-precise risk equations, mostly serves to justify expanding the statin market into younger, lower-absolute-risk people. The real conversation about individual long-term benefit-risk (muscle, metabolic, and cognitive side effects that are documented but consistently downplayed) is basically missing from the guideline debate. The fact that the first oral PCSK9 inhibitor (enlicitide) got FDA clearance the same week as these new guidelines probably isn’t just a scheduling coincidence
.
My N=1: I refuse to take statins despite elevated cholesterol numbers (a deliberate choice — I think the current guidelines are set too low). Statin side effects are not something to brush off.
🧬 The Ultimate Guide to Biohacking & Longevity is a reader-supported publication. 💌 To receive new posts and support my work, consider becoming a free or paid subscriber. 🚀
🍉 Longevity Recipe — Watermelon-Coconut Ice Cream
This five-minute granita is my go-to summer dessert — and it’s not a random pick this week: watermelon is loaded with citrulline, a precursor to nitric oxide that supports vasodilation and endothelial function — exactly the territory you want to protect when you’re talking cardiovascular health (see the statin story above).
It also brings lycopene, a cardioprotective antioxidant. Coconut cream adds healthy fats, and stevia skips the blood sugar spike of a regular sweetened dessert.
→ Freeze 4 cups (about half a small watermelon) of watermelon flesh, cubed → Let sit at room temp for 5-10 minutes to soften slightly → Add coconut milk and a few drops of stevia ( you can also add some vanilla extract) → Scrape with a fork until you get a granita texture and voila ¡
🧬 The Ultimate Guide to Biohacking & Longevity is a reader-supported publication. 💌 To receive new posts and support my work, consider becoming a free or paid subscriber. 🚀
Let’s keep going! Forza!
Valérie Orsoni Biohacker since 1998 | Longevity Expert
🎙 Life Summit— Berlin (29-30 mai 2026) 🎙 Corsica Biohacking — Corsica (6-13 juin 2026) 🎙 Biohackers World Conference — New York (juin 2026) 🎙 RAADFest— Sedona (4-6 septembre 2026) 🎙 HealthSpan Summit — Los Angeles (2–4 oct. 2026) 🎙 Reclaiming Health & Longevity Symposium — El Salvador (8–9 nov. 2026) 🎙 Biohackers World Conference — Miami (jan 2027)
Disclaimer: This article reflects one individual’s personal experience, research, and interpretation of scientific information. It is not medical advice and should not be used as a substitute for professional diagnosis or treatment. Health conditions—whether metabolic, hormonal, digestive, neurological, cardiovascular, immune-related, or otherwise—can vary widely in severity and may require urgent or specialized medical care. Always seek advice from qualified healthcare professionals before beginning, changing, or discontinuing any medication, supplement, lifestyle protocol, or therapeutic approach. Personal experiences described here, including mild or atypical presentations, are not representative of all clinical situations or of serious or acute medical conditions requiring immediate attention.
